Cytek Biosciences (CTKB) Operating Margin (2020 - 2026)
Cytek Biosciences posted quarterly Operating Margin of 41.83% for Q1 2026, down 571.0% year-on-year from 8.88% in Q1 2025, and down 364.7% on a QoQ basis from 9.0% in Q4 2025.
Cytek Biosciences (CTKB) has 7 years of Operating Margin data on file, last reported at 41.83% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 571.0% year-over-year to 41.83%; the trailing twelve-month figure through Mar 2026 stood at 21.49% (down 892.0% YoY), and the FY2025 full-year result was 20.04%, down 980.0% from the prior year.
- Operating Margin for Q1 2026 stood at 41.83%, down from 9.0% in the prior quarter.
- Across five years, Operating Margin topped out at 5.2% in Q4 2024 and bottomed at 41.83% in Q1 2026.
- The 5-year median for Operating Margin is 13.38% (2023), against an average of 14.31%.
- The widest annual swing landed in 2023, when Operating Margin plunged 2607 bps; it then jumped 886 bps in 2024.
- A 5-year view of Operating Margin shows it stood at 0.17% in 2022, then slumped by 235 bps to 0.24% in 2023, then soared by 2308 bps to 5.2% in 2024, then sank by 273 bps to 9.0% in 2025, then sank by 365 bps to 41.83% in 2026.
- The last three Operating Margin figures came in at 41.83% (Q1 2026), 9.0% (Q4 2025), and 17.58% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -41.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.83% |
| Dec 31, 2025 | -9.00% |
| Sep 30, 2025 | -17.58% |
| Jun 30, 2025 | -23.30% |
| Mar 31, 2025 | -36.12% |
| Dec 31, 2024 | 5.20% |
| Sep 30, 2024 | -8.25% |
| Jun 30, 2024 | -18.29% |
| Mar 31, 2024 | -23.93% |
| Dec 31, 2023 | -0.24% |
| Sep 30, 2023 | -13.38% |
| Jun 30, 2023 | -18.37% |
| Mar 31, 2023 | -32.79% |
| Dec 31, 2022 | 0.17% |
| Sep 30, 2022 | 3.36% |
| Jun 30, 2022 | -2.22% |
| Mar 31, 2022 | -6.72% |
| Dec 31, 2021 | -1.52% |
| Sep 30, 2021 | 8.43% |
| Jun 30, 2021 | 12.53% |
| Mar 31, 2021 | 4.66% |
| Dec 31, 2020 | -12.80% |
| Sep 30, 2020 | 26.74% |
| Jun 30, 2020 | -1.14% |